University Of Birmingham
Clinical trials sponsored by University Of Birmingham, explained in plain language.
-
Hope for kids with tough cancer: new drug combo shows promise
Disease control CompletedThis study tested whether adding the drug bevacizumab (which blocks blood vessel growth to tumors) to standard chemotherapy helps children with neuroblastoma that has come back or not responded to treatment. It also looked at adding other chemotherapy drugs like irinotecan or top…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 03:27 UTC
-
Could a common drug slow vision loss in rare wolfram syndrome?
Disease control CompletedThis study tested whether sodium valproate, a drug already used for other conditions, can help people with Wolfram syndrome—a rare genetic disorder that causes diabetes, vision loss, and other problems. The trial included 63 children and adults who were randomly assigned to recei…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 03:27 UTC
-
Lung cancer trial matches drugs to genes: a step toward personalized treatment
Disease control CompletedThis trial tested several targeted drugs in people with non-small cell lung cancer whose tumors had specific genetic markers. The goal was to see if these drugs could shrink tumors or delay cancer growth. Over 400 participants received treatment tailored to their cancer's genetic…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Immunotherapy shows promise for Hard-to-Treat bowel cancer
Disease control CompletedThis study tested the drug nivolumab in 35 people with a certain kind of advanced colorectal cancer that has not responded to standard treatments. The goal was to see if the drug could stop the cancer from growing for at least 27 weeks. The trial is complete, and results help und…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Cocoa drink may shield aging arteries from sitting damage
Symptom relief CompletedThis study looked at whether a cocoa drink rich in flavanols could protect blood vessel function and blood pressure in healthy older adults (65+) during 2 hours of sitting. Twenty participants drank either a high-flavanol or low-flavanol cocoa before sitting, and their artery hea…
Phase: NA • Sponsor: University of Birmingham • Aim: Symptom relief
Last updated May 26, 2026 03:05 UTC